The Global Coated Endotracheal Tube Market size is expected to reach $238.2 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 9,493.1 thousand units experiencing a growth of 8.9% (2019-2022).
Respiratory conditions, including those requiring intubation, are prevalent in the Asia Pacific region. There is a growing awareness among healthcare professionals in the APAC region regarding the latest advancements in medical technologies. Consequently, the Asia Pacific region would acquire nearly 30% of the total market share by 2030. The growth of medical tourism increases the demand for advanced medical facilities and technologies in the region. These tubes, known for their benefits in respiratory care, contribute to the attractiveness of healthcare facilities in the Asia Pacific region. Some of the factors impacting the market are the growing prevalence of respiratory diseases, the increasing number of senior citizens and the high initial cost of these tubes.
The rising incidence of respiratory diseases globally drives the demand for advanced respiratory care solutions. These tubes, with their features aimed at minimizing complications, are increasingly used to manage respiratory diseases, contributing to market growth. Ventilator-associated pneumonia (VAP) is a common complication in ventilated patients with respiratory diseases. These tubes with anti-microbial properties play a crucial role in preventing VAP. By reducing the risk of respiratory infections, these tubes contribute to better outcomes for patients with respiratory diseases. The market is expanding significantly due to the growing prevalence of respiratory diseases. Additionally, as per the WHO, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050. Elderly patients often have unique healthcare needs, including a focus on comfort and well-being. These tubes, with features such as smoother surfaces and reduced friction, enhance patient comfort during intubation and ventilation. As a result of the increasing number of senior citizens, the market is anticipated to increase significantly.
Moreover, the surge in COVID-19 cases led to an increased demand for mechanical ventilation and, consequently, endotracheal intubation in severe cases. The risk of healthcare-associated infections, including VAP, became a critical concern during the pandemic. The pandemic prompted a shift in healthcare priorities, with an increased focus on critical care, respiratory support, and infection control measures. Thus, the COVID-19 pandemic had a positive effect on the market.
However, these tubes often cost more upfront than traditional uncoated tubes. The cost factor can be a barrier to adoption, particularly in healthcare systems where budget constraints are a significant concern. Reimbursement policies may not always align with the higher cost of advanced medical technologies. Healthcare providers may face challenges in securing adequate reimbursement for these tubes. This discrepancy between cost and reimbursement can discourage adoption, particularly if it affects the financial viability of healthcare institutions. Thus, high initial cost of these tubes can slow down the growth of the market.
Intubation Outlook
Based on intubation, the market is classified into orotracheal and nasotracheal. The nasotracheal segment acquired a substantial revenue share in the market in 2022. Nasotracheal intubation involves the passage of the tube through the smaller nasal passages, and coated tubes can contribute to smoother insertion, minimizing trauma. The reduced friction can be particularly beneficial in nasotracheal intubation procedures, potentially leading to increased adoption. These tubes, with their anti-microbial properties, contribute to infection prevention measures during nasotracheal intubation.
End User Outlook
By end user, the market is categorized into hospitals, clinics, and ambulatory surgical centres. The clinics segment covered a considerable revenue share in the market in 2022. Clinics increasingly incorporate innovative healthcare technologies into their practices, including advanced endotracheal tubes with smart features. Integrating smart technologies, such as sensors and monitoring capabilities, enhances patient monitoring and facilitates real-time data collection in clinic settings. This drive for innovation contributes to adopting these tubes with advanced functionalities.
Application Outlook
On the basis of application, the market is divided into anesthesia, emergency medicine, and others. The emergency medicine segment recorded a remarkable revenue share in the market in 2022. Emergency medicine involves many clinical scenarios, from trauma cases to respiratory distress. Emergency medicine often deals with trauma cases and critical interventions requiring rapid intubation. These tubes, focusing on reducing complications and providing a smooth intubation process, are valuable in managing trauma cases and critical emergencies, improving the efficiency of airway management.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Patient safety and care quality are paramount concerns within North America's healthcare system. North America boasts advanced healthcare infrastructure and a robust medical technology landscape. The region's well-developed healthcare facilities are more inclined to adopt innovative technologies, including these tubes. The region's higher incidence of respiratory challenges drives the demand for technologies that minimize complications.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH
Scope of the Study
Market Segments covered in the Report:
By Intubation (Volume, Thousand Units, USD Million, 2019-2030)
By End User (Volume, Thousand Units, USD Million, 2019-2030)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Application (Volume, Thousand Units, USD Million, 2019-2030)
- Anesthesia
- Emergency Medicine
- Others
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Sonoma Pharmaceuticals Inc.
- Becton, Dickinson, and Company
- Bactiguard Holding AB (publ)
- Sharklet Technologies, Inc.
- Medline Industries, LP
- N8 Medical, LLC
- Armstrong Medical Ltd (Eakin Healthcare Ltd)
- Teleflex, Inc.
- Venner Medical (Deutschland) GmbH
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Coated Endotracheal Tube Market, by Intubation
- 1.4.2 Global Coated Endotracheal Tube Market, by End User
- 1.4.3 Global Coated Endotracheal Tube Market, by Application
- 1.4.4 Global Coated Endotracheal Tube Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Global Coated Endotracheal Tube Market by Intubation
- 4.1 Global Orotracheal Market by Region
- 4.2 Global Nasotracheal Market by Region
Chapter 5. Global Coated Endotracheal Tube Market by End User
- 5.1 Global Hospitals Market by Region
- 5.2 Global Clinics Market by Region
- 5.3 Global Ambulatory Surgical Centers Market by Region
Chapter 6. Global Coated Endotracheal Tube Market by Application
- 6.1 Global Anesthesia Market by Region
- 6.2 Global Emergency Medicine Market by Region
- 6.3 Global Others Market by Region
Chapter 7. Global Coated Endotracheal Tube Market by Region
- 7.1 North America Coated Endotracheal Tube Market
- 7.1.1 North America Coated Endotracheal Tube Market by Intubation
- 7.1.1.1 North America Orotracheal Market by Country
- 7.1.1.2 North America Nasotracheal Market by Country
- 7.1.2 North America Coated Endotracheal Tube Market by End User
- 7.1.2.1 North America Hospitals Market by Country
- 7.1.2.2 North America Clinics Market by Country
- 7.1.2.3 North America Ambulatory Surgical Centers Market by Country
- 7.1.3 North America Coated Endotracheal Tube Market by Application
- 7.1.3.1 North America Anesthesia Market by Country
- 7.1.3.2 North America Emergency Medicine Market by Country
- 7.1.3.3 North America Others Market by Country
- 7.1.4 North America Coated Endotracheal Tube Market by Country
- 7.1.4.1 US Coated Endotracheal Tube Market
- 7.1.4.1.1 US Coated Endotracheal Tube Market by Intubation
- 7.1.4.1.2 US Coated Endotracheal Tube Market by End User
- 7.1.4.1.3 US Coated Endotracheal Tube Market by Application
- 7.1.4.2 Canada Coated Endotracheal Tube Market
- 7.1.4.2.1 Canada Coated Endotracheal Tube Market by Intubation
- 7.1.4.2.2 Canada Coated Endotracheal Tube Market by End User
- 7.1.4.2.3 Canada Coated Endotracheal Tube Market by Application
- 7.1.4.3 Mexico Coated Endotracheal Tube Market
- 7.1.4.3.1 Mexico Coated Endotracheal Tube Market by Intubation
- 7.1.4.3.2 Mexico Coated Endotracheal Tube Market by End User
- 7.1.4.3.3 Mexico Coated Endotracheal Tube Market by Application
- 7.1.4.4 Rest of North America Coated Endotracheal Tube Market
- 7.1.4.4.1 Rest of North America Coated Endotracheal Tube Market by Intubation
- 7.1.4.4.2 Rest of North America Coated Endotracheal Tube Market by End User
- 7.1.4.4.3 Rest of North America Coated Endotracheal Tube Market by Application
- 7.2 Europe Coated Endotracheal Tube Market
- 7.2.1 Europe Coated Endotracheal Tube Market by Intubation
- 7.2.1.1 Europe Orotracheal Market by Country
- 7.2.1.2 Europe Nasotracheal Market by Country
- 7.2.2 Europe Coated Endotracheal Tube Market by End User
- 7.2.2.1 Europe Hospitals Market by Country
- 7.2.2.2 Europe Clinics Market by Country
- 7.2.2.3 Europe Ambulatory Surgical Centers Market by Country
- 7.2.3 Europe Coated Endotracheal Tube Market by Application
- 7.2.3.1 Europe Anesthesia Market by Country
- 7.2.3.2 Europe Emergency Medicine Market by Country
- 7.2.3.3 Europe Others Market by Country
- 7.2.4 Europe Coated Endotracheal Tube Market by Country
- 7.2.4.1 Germany Coated Endotracheal Tube Market
- 7.2.4.1.1 Germany Coated Endotracheal Tube Market by Intubation
- 7.2.4.1.2 Germany Coated Endotracheal Tube Market by End User
- 7.2.4.1.3 Germany Coated Endotracheal Tube Market by Application
- 7.2.4.2 UK Coated Endotracheal Tube Market
- 7.2.4.2.1 UK Coated Endotracheal Tube Market by Intubation
- 7.2.4.2.2 UK Coated Endotracheal Tube Market by End User
- 7.2.4.2.3 UK Coated Endotracheal Tube Market by Application
- 7.2.4.3 France Coated Endotracheal Tube Market
- 7.2.4.3.1 France Coated Endotracheal Tube Market by Intubation
- 7.2.4.3.2 France Coated Endotracheal Tube Market by End User
- 7.2.4.3.3 France Coated Endotracheal Tube Market by Application
- 7.2.4.4 Russia Coated Endotracheal Tube Market
- 7.2.4.4.1 Russia Coated Endotracheal Tube Market by Intubation
- 7.2.4.4.2 Russia Coated Endotracheal Tube Market by End User
- 7.2.4.4.3 Russia Coated Endotracheal Tube Market by Application
- 7.2.4.5 Spain Coated Endotracheal Tube Market
- 7.2.4.5.1 Spain Coated Endotracheal Tube Market by Intubation
- 7.2.4.5.2 Spain Coated Endotracheal Tube Market by End User
- 7.2.4.5.3 Spain Coated Endotracheal Tube Market by Application
- 7.2.4.6 Italy Coated Endotracheal Tube Market
- 7.2.4.6.1 Italy Coated Endotracheal Tube Market by Intubation
- 7.2.4.6.2 Italy Coated Endotracheal Tube Market by End User
- 7.2.4.6.3 Italy Coated Endotracheal Tube Market by Application
- 7.2.4.7 Rest of Europe Coated Endotracheal Tube Market
- 7.2.4.7.1 Rest of Europe Coated Endotracheal Tube Market by Intubation
- 7.2.4.7.2 Rest of Europe Coated Endotracheal Tube Market by End User
- 7.2.4.7.3 Rest of Europe Coated Endotracheal Tube Market by Application
- 7.3 Asia Pacific Coated Endotracheal Tube Market
- 7.3.1 Asia Pacific Coated Endotracheal Tube Market by Intubation
- 7.3.1.1 Asia Pacific Orotracheal Market by Country
- 7.3.1.2 Asia Pacific Nasotracheal Market by Country
- 7.3.2 Asia Pacific Coated Endotracheal Tube Market by End User
- 7.3.2.1 Asia Pacific Hospitals Market by Country
- 7.3.2.2 Asia Pacific Clinics Market by Country
- 7.3.2.3 Asia Pacific Ambulatory Surgical Centers Market by Country
- 7.3.3 Asia Pacific Coated Endotracheal Tube Market by Application
- 7.3.3.1 Asia Pacific Anesthesia Market by Country
- 7.3.3.2 Asia Pacific Emergency Medicine Market by Country
- 7.3.3.3 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Coated Endotracheal Tube Market by Country
- 7.3.4.1 China Coated Endotracheal Tube Market
- 7.3.4.1.1 China Coated Endotracheal Tube Market by Intubation
- 7.3.4.1.2 China Coated Endotracheal Tube Market by End User
- 7.3.4.1.3 China Coated Endotracheal Tube Market by Application
- 7.3.4.2 Japan Coated Endotracheal Tube Market
- 7.3.4.2.1 Japan Coated Endotracheal Tube Market by Intubation
- 7.3.4.2.2 Japan Coated Endotracheal Tube Market by End User
- 7.3.4.2.3 Japan Coated Endotracheal Tube Market by Application
- 7.3.4.3 India Coated Endotracheal Tube Market
- 7.3.4.3.1 India Coated Endotracheal Tube Market by Intubation
- 7.3.4.3.2 India Coated Endotracheal Tube Market by End User
- 7.3.4.3.3 India Coated Endotracheal Tube Market by Application
- 7.3.4.4 South Korea Coated Endotracheal Tube Market
- 7.3.4.4.1 South Korea Coated Endotracheal Tube Market by Intubation
- 7.3.4.4.2 South Korea Coated Endotracheal Tube Market by End User
- 7.3.4.4.3 South Korea Coated Endotracheal Tube Market by Application
- 7.3.4.5 Singapore Coated Endotracheal Tube Market
- 7.3.4.5.1 Singapore Coated Endotracheal Tube Market by Intubation
- 7.3.4.5.2 Singapore Coated Endotracheal Tube Market by End User
- 7.3.4.5.3 Singapore Coated Endotracheal Tube Market by Application
- 7.3.4.6 Malaysia Coated Endotracheal Tube Market
- 7.3.4.6.1 Malaysia Coated Endotracheal Tube Market by Intubation
- 7.3.4.6.2 Malaysia Coated Endotracheal Tube Market by End User
- 7.3.4.6.3 Malaysia Coated Endotracheal Tube Market by Application
- 7.3.4.7 Rest of Asia Pacific Coated Endotracheal Tube Market
- 7.3.4.7.1 Rest of Asia Pacific Coated Endotracheal Tube Market by Intubation
- 7.3.4.7.2 Rest of Asia Pacific Coated Endotracheal Tube Market by End User
- 7.3.4.7.3 Rest of Asia Pacific Coated Endotracheal Tube Market by Application
- 7.4 LAMEA Coated Endotracheal Tube Market
- 7.4.1 LAMEA Coated Endotracheal Tube Market by Intubation
- 7.4.1.1 LAMEA Orotracheal Market by Country
- 7.4.1.2 LAMEA Nasotracheal Market by Country
- 7.4.2 LAMEA Coated Endotracheal Tube Market by End User
- 7.4.2.1 LAMEA Hospitals Market by Country
- 7.4.2.2 LAMEA Clinics Market by Country
- 7.4.2.3 LAMEA Ambulatory Surgical Centers Market by Country
- 7.4.3 LAMEA Coated Endotracheal Tube Market by Application
- 7.4.3.1 LAMEA Anesthesia Market by Country
- 7.4.3.2 LAMEA Emergency Medicine Market by Country
- 7.4.3.3 LAMEA Others Market by Country
- 7.4.4 LAMEA Coated Endotracheal Tube Market by Country
- 7.4.4.1 Brazil Coated Endotracheal Tube Market
- 7.4.4.1.1 Brazil Coated Endotracheal Tube Market by Intubation
- 7.4.4.1.2 Brazil Coated Endotracheal Tube Market by End User
- 7.4.4.1.3 Brazil Coated Endotracheal Tube Market by Application
- 7.4.4.2 Argentina Coated Endotracheal Tube Market
- 7.4.4.2.1 Argentina Coated Endotracheal Tube Market by Intubation
- 7.4.4.2.2 Argentina Coated Endotracheal Tube Market by End User
- 7.4.4.2.3 Argentina Coated Endotracheal Tube Market by Application
- 7.4.4.3 UAE Coated Endotracheal Tube Market
- 7.4.4.3.1 UAE Coated Endotracheal Tube Market by Intubation
- 7.4.4.3.2 UAE Coated Endotracheal Tube Market by End User
- 7.4.4.3.3 UAE Coated Endotracheal Tube Market by Application
- 7.4.4.4 Saudi Arabia Coated Endotracheal Tube Market
- 7.4.4.4.1 Saudi Arabia Coated Endotracheal Tube Market by Intubation
- 7.4.4.4.2 Saudi Arabia Coated Endotracheal Tube Market by End User
- 7.4.4.4.3 Saudi Arabia Coated Endotracheal Tube Market by Application
- 7.4.4.5 South Africa Coated Endotracheal Tube Market
- 7.4.4.5.1 South Africa Coated Endotracheal Tube Market by Intubation
- 7.4.4.5.2 South Africa Coated Endotracheal Tube Market by End User
- 7.4.4.5.3 South Africa Coated Endotracheal Tube Market by Application
- 7.4.4.6 Nigeria Coated Endotracheal Tube Market
- 7.4.4.6.1 Nigeria Coated Endotracheal Tube Market by Intubation
- 7.4.4.6.2 Nigeria Coated Endotracheal Tube Market by End User
- 7.4.4.6.3 Nigeria Coated Endotracheal Tube Market by Application
- 7.4.4.7 Rest of LAMEA Coated Endotracheal Tube Market
- 7.4.4.7.1 Rest of LAMEA Coated Endotracheal Tube Market by Intubation
- 7.4.4.7.2 Rest of LAMEA Coated Endotracheal Tube Market by End User
- 7.4.4.7.3 Rest of LAMEA Coated Endotracheal Tube Market by Application
Chapter 8. Company Profiles
- 8.1 Sonoma Pharmaceuticals, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Becton, Dickinson, and Company
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Bactiguard Holding AB (publ)
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Recent strategies and developments:
- 8.3.4.1 Acquisition and Mergers:
- 8.3.5 SWOT Analysis
- 8.4 Sharklet Technologies, Inc.
- 8.4.1 Company Overview
- 8.4.2 SWOT Analysis
- 8.5 Medline Industries, LP
- 8.5.1 Company Overview
- 8.5.2 SWOT Analysis
- 8.6 N8 Medical, LLC
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Product Launches and Product Expansions:
- 8.6.2.2 Trials & Approvals:
- 8.6.3 SWOT Analysis
- 8.7 Armstrong Medical Ltd (Eakin Healthcare Ltd)
- 8.7.1 Company Overview
- 8.7.2 SWOT Analysis
- 8.8 Teleflex, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
- 8.9 Venner Medical (Deutschland) GmbH
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
Chapter 9. Winning Strategies of Coated Endotracheal Tube Market